Bundling in Dexcom’s CGM tech will “improve health outcomes by ... healthcare team with important real-time data that can help alleviate the burden of diabetes management, including overall ...

The latest trend in earnings estimate revisions might not help the stock continue moving ... Investing.com -- Baird upgraded DexCom Inc (NASDAQ:DXCM). to "Outperform" from "Neutral," citing ...

Matthew Taylor, an analyst from Jefferies, reiterated the Buy rating on Dexcom (DXCM – Research Report). The associated price target remains the same with $100.00. Discover outperforming stocks ...

Hear of anything happening at Dexcom or another California tech company? Contact tech reporter ... Arizona, “to support our ...